SPS 2017 Program SPS 2017 Program - Page 32

Conclusion: The MTM telepharmacist and nurse played inte- gral roles in facilitating and streamlining focused follow-up appointments between the patient and provider to promptly resolve patient concerns and therapeutic issues. Interprofes- sional collaboration between the pharmacists and outpatient providers resulted in identification of recommendations re- garding: treatment guidelines, dosage adjustments, monitor- ing parameters, and drug/disease-drug interactions. Future research is needed to determine the impact of longer-term transitional care programs on the number of telepharmacist interventions made and subsequent provider acceptance rates. 5. Interprofessional Medication Therapy Management Services via Collaborative Video Conferencing Technology for Patients with Epilepsy Kate Johnson, BSN, RN, Jennifer Bingham, PharmD, David Rhys Axon, MPharm, Sandra Leal, PharmD, MPH SinfonΓ­aRx, University of Arizona Medication Management Center Background: Patients with epilepsy often face challenges with access to healthcare and management of their condi- tions. 1) Additionally, patients living in rural areas typically have poorer access to clinical pharmacy services than their urban counterparts. 2) Limited literature exists regarding in- terprofessiona °½±±…‰½Ι…Ρ₯½ΈΩ₯„Ω₯‘•Ό½Ή™•Ι•Ή₯Ήœ™½ΘΡ‘•Ν”)Α…Ρ₯•ΉΡΜΈ)5•Ρ‘½‘Μ聁UΉ₯Ω•ΙΝ₯Ρ䁽˜Ι₯ι½Ή„5•‘₯…Ρ₯½Έ5…Ή…•΅•ΉΠ) •ΉΡ•Θ€‘U55 €±₯Ή₯…°Ρ•±•Α‘…Ι΅…₯ΝЁΑ…ΙΡ₯₯Α…Ρ•₯Έέ••¬΄)±δ°½±±…‰½Ι…Ρ₯Ω”Ω₯‘•Ό½Ή™•Ι•Ή₯Ήœ…ΑΑ½₯ΉΡ΅•ΉΡ́‰•Ρέ••Έ)Α₯±•ΑΝ䁽չ‘…Ρ₯½ΈΑ…Ρ₯•ΉΡ́…ΉΡ‘•₯ȁ•Α₯±•ΑΡ½±½₯ΝΠΈΥΙ₯Ήœ)Ρ‘”½ΉΝΥ±Ρ…Ρ₯½Έ°Ρ‘”U55 Ρ•±•Α‘…Ι΅…₯ΝΠθΑ•Ι™½Ι΅•„)½΅ΑΙ•‘•ΉΝ₯Ω”΅•‘₯…Ρ₯½ΈΙ•Ω₯•ά€‘ 5H€μ•Ω…±Υ…Ρ•Ρ‘”Α„΄)Ρ₯•ΉΣŠé΅•‘₯…Ρ₯½Έ±₯ΝЁ™½ΘΝ…™•Ρ䁍½Ή•ΙΉΜ…Ή΅•‘₯…Ρ₯½Έ΄)Ι•±…Ρ•ΑΙ½‰±•΅Μ€‘5IAΜ€μΑΙ½Ω₯‘•Α…Ρ₯•ΉΠ½ΥΉΝ•±₯Ήœμ…Ή)½±±…‰½Ι…Ρ•έ₯Ρ Ρ‘”•Α₯±•ΑΡ½±½₯ΝЁ½Έ±₯Ή₯…°‘•₯Ν₯½Έ΅…¬΄)₯Ήœ€‘”ΉœΈ°‘½Ν₯Ήœ°Ν₯‘”•™™•ΡΜ°…ΉΑ‘…Ι΅…δ΅Ι•±…Ρ•ΕΥ•Μ΄)Ρ₯½ΉΜ€Έ… Α…Ρ₯•ΉΠΙ••₯Ω•„ΡεΑ•έΙ₯ΡΡ•Έ΅•‘₯…Ρ₯½Έ±₯ΝЁ…Ή)Α•ΙΝ½Ή…±₯镐…Ρ₯½ΈΑ±…ΈΩ₯„΅…₯°°™½±±½έ₯Ήœ‘₯Μ½‘•Θ…ΑΑ½₯ΉΠ΄)΅•ΉΠΈA…Ρ₯•ΉΡ́ɕ•₯Ω•„™½±±½ά΅ΥΐΑ‘½Ή”…±°™Ι½΄Ρ‘”)U55 Ρ•±•Α‘…Ι΅…₯ΝЁёɕ”ΡΌΝ₯ΰ΅½ΉΡ‘́…™Ρ•ΘΡ‘”₯Ή₯Ρ₯…°)Ι•Ω₯•ά°‘•Α•Ή‘₯Ήœ½ΈΡ‘”Ν•Ω•Ι₯Ρ䁽˜½Ή•ΙΉΜ₯‘•ΉΡ₯™₯•₯Ή€΄)Ρ₯…±±δΈQ‘”Ρ•±•Α‘…Ι΅…₯ΝЁ‘½Υ΅•ΉΡ•Ή½Ρ•Μ…Ή΅•‘₯…Ρ₯½Έ΄)Ι•±…Ρ•Ι•½΅΅•Ή‘…Ρ₯½ΉΜ₯ΈΡ‘”Α₯±•ΑΝ䁽չ‘…Ρ₯½»Šé•±•Œ΄)ΡΙ½Ή₯Œ‘•…±Ρ Ι•½Ι™½±±½έ₯Ήœ…±°½ΉΝΥ±Ρ…Ρ₯½ΉΜΈ)I•ΝΥ±ΡΜθ%Ή₯Ρ₯…° 5Íݕɔ½΅Α±•Ρ•έ₯Ρ €Ψ́Α…Ρ₯•ΉΡ́ɔ΄)ΝΥ±Ρ₯Ήœ₯Έ₯‘•ΉΡ₯™₯…Ρ₯½Έ½˜θ€Ψ؁‘Ι՜΅‘Ι՜₯ΉΡ•Ι…Ρ₯½ΉΜμ€Μά)…‘Ω•ΙΝ”‘Ι՜Ι•…Ρ₯½ΉΜμ€Μԁ‘½Ν”΅Ι•±…Ρ•Ν…™•Ρ䁍½Ή•ΙΉΜμ€ΔΜ)Ρ‘•Ι…Α•ΥΡ₯Œ‘ΥΑ±₯…Ρ₯½ΉΜ쁅Ή€Δ́‘Ι՜΅‘₯Ν•…Ν”₯ΉΡ•Ι…Ρ₯½ΉΜΈ)A…Ρ₯•ΉΡ́‘……Έ…Ω•Ι…”½˜€ΘΈΨΐ€‘Mθ€ΘΈΔΠ€5IÁ₯‘•ΉΡ₯™₯•Α•Θ)Α•ΙΝ½ΈΈI½Υ‘±δ½Ή”™₯™Ρ € ΔάΈΤ”€½˜Α…Ρ₯•ΉΡ͕́±˜΅Ι•Α½ΙΡ•+ŠqΝ½΅•Ρ₯΅•ΟŠt°ƒŠq½™Ρ•»Št°½ΘƒŠqΩ•Ι䁽™Ρ•»Št™½Ι•ΡΡ₯ΉœΡΌΡ…­”Ρ‘•₯Θ)΅•‘₯…Ρ₯½ΉΜ₯ΈΡ‘”Α…ΝЁ΅½ΉΡ °ΑΙ½΅ΑΡ₯Ήœ…‘‘₯Ρ₯½Ή…°Ρ•±”΄)Α‘…Ι΅…₯ΝΠ΅‘•±₯Ω•Ι•…‘‘•Ι•Ή”½ΥΉΝ•±₯ΉœΈ) ½Ή±ΥΝ₯½ΉΜθAΙ•±₯΅₯Ή…Ι䁅Ή…±εΝ₯́ɕٕ…±•Α½Ν₯Ρ₯Ω”ΑΙ½Ι…΄)½Υэ½΅•Μ°Ν՝•ΝΡ₯ΉœΡ‘…Ёё₯́ѕ±•‘•…±Ρ ΑΙ½Ι…΄½™™•Ί„)Ή½Ω•°…Ή™•…Ν₯‰±”Ν½±ΥΡ₯½Έ™½Θ₯ΉΡ•Ι…Ρ₯Ήœ±₯Ή₯…°Α‘…Ι΅…₯ΝΡΜ)₯ΉΡΌΝΡ…Ή‘…ɐ•Α₯±•ΑΝ䁍…Ι”…Ή₯ΉΙ•…Ν₯ΉœΙ•ΝΑ•Ρ₯Ω”ΙΥΙ…°)Α…Ρ₯•ΉΡϊd…•Ν́Ѽ5Q4Ν•ΙΩ₯•ΜΈΥΡΥΙ”Ι•Ν•…ɍ ₯́Ή••‘•)ΡΌ•α…΅₯Ή”Ρ‘”½ΝЁ•™™•Ρ₯Ω•Ή•Ν́½˜Ρ‘₯́ΡεΑ”½˜½±±…‰½Ι…Ρ₯½Έ)…Ή•αΑ±½Ι”Α…Ρ₯•ΉΠ΅Ι•±…Ρ•½Υэ½΅•Μ₯Έ‘₯Ω•ΙΝ”Α½ΑΥ±…Ρ₯½ΉΜ)…Ή±₯Ή₯…°Ν•ΡΡ₯ΉΜΈ(ΨΈ]‘…Ё5…­•Μ…Έ™™•Ρ₯Ω”U͕ȁ%ΉΡ•Ι™…”)™½ΘY₯ΙΡΥ…° …Ι”M½±ΥΡ₯½ΉΜό)M½ΡЁ Ι½έΈ…Ή-•Ω₯Έ0ΈM΅₯Ρ °9@°9@°9@)i₯ΑΉ½Ν₯Μ°%ΉŒΈ) …­Ι½ΥΉθ%ΉΉ½Ω…Ρ₯Ω”…Ι”‘•±₯Ω•ΙδΡ‘ɽ՝ Ω₯ΙΡΥ…°…Ι”)‘½±‘́•Ή½Ι΅½ΎΑ½Ρ•ΉΡ₯…°™½Θ‘Ι₯Ω₯Ήœ…Ι”ΕΥ…±₯Ρ䁅Ή•™™₯₯•Έ΄)δ°ΥΝΡ½΅₯ι₯ΉœΝΥΑΑ½ΙЁ™½ΘΑ…Ρ₯•ΉΡΜ°…ΉΑΙ½΅½Ρ₯ΉœΑ…Ρ₯•ΉΠ)•Ή…•΅•ΉΠΡΌΑΙ½‘Ս”Α½Ν₯Ρ₯Ω”‘•…±Ρ ½Υэ½΅•ΜΈ!½έ•Ω•Θ°)‰•™½Ι”Ω₯ΙΡΥ…°…Ι”…Έ…‘₯•Ω”₯Ρ́Α½Ρ•ΉΡ₯…°°Α…Ρ₯•ΉΡ́Ή••ΡΌ)•΅‰Ι…”₯ΠΈU͕ȁ•αΑ•Ι₯•Ή”€‘U`€Α±…έ„­•δΙ½±”₯Έ‘Ι₯Ω₯Ήœ)…‘½ΑΡ₯½Έ½˜‘₯₯Ρ…°‘•…±Ρ Ρ•‘Ή½±½₯•Μ±₯­”Ω₯ΙΡΥ…°…Ι”Έ%Έ)™…Π°…‘½ΑΡ₯½Έ…ΉΝΥΝΡ…₯Ή•ΥΝ”½˜Ρ•‘Ή½±½δ…Ι”Ρ₯•‘₯Ι•Π΄)±δΡΌ•…Ν”½˜ΥΝ”…ΉΡ‘”Α•Ι•₯Ω•ΥΡ₯±₯Ρ䁽˜…Ω…₯±…‰±”₯Ή™½Θ΄)΅…Ρ₯½ΈΈ)5•Ρ‘½‘Μθi₯ΑΉ½Ν₯́Α…ΙΡΉ•Ι•έ₯Ρ „Υ͕ȁ•αΑ•Ι₯•Ή”½Έ΄)ΝΥ±Ρ₯Ήœ™₯Ι΄ΡΌΑ•Ι™½Ι΄„½΅ΑΙ•‘•ΉΝ₯Ω”U`Ι•Ν•…ɍ ΑΙ½©•ΠΈ)Q‘₯́ΑΙ½©•Π½ΉΝ₯ΝΡ•½˜€Δθā₯ΉΡ•ΙΩ₯•έ́‘ΥΙ₯Ήœέ‘₯ ΥΝ•ΙΜ)έ½Ι­•Ρ‘ɽ՝ „Ν•Ι₯•Μ½˜Ρ…ͭ́₯ΈΡ‘”…ΑΑ±₯…Ρ₯½ΈΈEΥ…±₯Ρ„΄)Ρ₯Ω”…ΉΕΥ…ΉΡ₯Ρ…Ρ₯Ω”‘…Ρ„έ…́½±±•Ρ•ΡΌ•Ω…±Υ…Ρ”Ρ‘”ΥΝ•Θ)•αΑ•Ι₯•Ή”‰½Ρ ‰•™½Ι”…Ή…™Ρ•ΘΙ•‘•Ν₯ΈΈ)I•ΝΥ±ΡΜθQ‘”₯ΉΡ•ΙΩ₯•έ́չ½Ω•Ι•Ν•Ω•Ι…°₯΅Α½ΙΡ…ΉΠ…Ι•…Μ)U`Ή••‘́Ѽ…‘‘Ι•ΝΜθ)…Ν”½˜ΥΝ—ŠQΡ‘”ΑΙ½•Ν́™½Θ…•ΝΝ₯Ήœ…Ι”Ή••‘́Ѽ‰”Ν₯΄΄)Α±”…Ή₯ΉΡΥ₯Ρ₯Ω”™½ΘΑ…Ρ₯•ΉΡ́…•ΝΝ₯Ήœ…Ι”Έ)αΑ•Ρ…Ρ₯½ΉΟŠQΑ…Ρ₯•ΉΡ́݅ΉΠΡΌ­Ή½άέ‘…ЁѼ•αΑ•ΠΙ•…ɐ΄)₯ΉœΑΙ½•ΝΜ°Α…ε΅•ΉΠ°…ΉΑ½ΝΝ₯‰±”½Υэ½΅•ΜΑΙ₯½ΘΡΌΝΡ…ΙΡ₯Ήœ)„Ω₯Ν₯ΠΈ)•Ή•Ι…Ρ₯½Ή…°ΑΙ•™•Ι•Ή•ΜƒŠQ‘₯™™•Ι•ΉΠ…”Ι½ΥΆΑΙ•™•ΙΙ•ΡΌ)₯ΉΡ•Ι…Πέ₯Ρ Ω₯ΙΡΥ…°…Ι”‘₯™™•Ι•ΉΡ±δ°…ΉΉ••‘•Ω…Ιε₯Ήœ±•Ψ΄)•±Μ½˜…ΝΝ₯ΝΡ…Ή”Ρ‘ɽ՝‘½ΥЁё”ΑΙ½•ΝΜΈ)΅Α…Ρ‘ηŠQΑ…Ρ₯•ΉΡ́ݕɔΝ••­₯Ήœ•΅Α…Ρ‘•Ρ₯Œ±…ΉΥ…”₯Έ‘₯€΄)Ρ…°₯ΉΡ•Ι…Ρ₯½ΉΜ°©ΥΝЁ…́ё•δέ½Υ±₯Έ…Έ₯Έ΅Α•ΙΝ½Έ₯ΉΡ•Ι…Ρ₯½Έ)έ₯Ρ „‘•…±Ρ‘…Ι”ΑΙ½Ω₯‘•ΘΈ) ½Ή±ΥΝ₯½ΉΜθA½ΝΠ΅Ι•‘•Ν₯Έ₯ΉΡ•ΙΩ₯•έ́₯Ή‘₯…Ρ”Ρ‘…Ё„ΥΝ•Θ΄)•ΉΡ•Ι•‘•Ν₯Έ₯ΈΩ₯ΙΡΥ…°…Ι”…Έ₯΅ΑΙ½Ω”Α…Ρ₯•ΉΠΝ…Ρ₯Ν™…Œ΄)Ρ₯½ΈΈQ‘”Ι•‘•Ν₯Ή•Α±…Ρ™½Ι΄₯́΅½Ω₯Ήœ₯ΉΡΌΑ₯±½ΠΑ‘…Ν”έ₯Ρ )Ν•Ω•Ι…°‘•…±Ρ ΝεΝΡ•΅ΜΈΉΡ₯₯Α…Ρ•Ι•ΝΥ±ΡΜ°‰…Ν•½ΈU`)₯ΉΡ•ΙΩ•ΉΡ₯½ΉΜ₯Έ„Ω…Ι₯•Ρ䁽˜₯Ή‘ΥΝΡΙ₯•Μ…ΉΝ½™Ρέ…Ι”ΑΙ½‘ՍΡΜ°)₯Ή±Υ‘”₯΅ΑΙ½Ω•…‘½ΑΡ₯½Έ°Ι•‘Ս•Ω₯Ν₯Ё…‰…Ή‘½Ή΅•ΉΠ°(ΜȁπA…”